Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.2K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.2K
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

2.9K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
2.9K
Urinary Bladder01:23

Urinary Bladder

3.3K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
3.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.2K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.2K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

1.5K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.5K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

3.3K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic Efficacy of Different Bladder Monotherapies Versus Multimodal Therapy in Patients with Interstitial Cystitis/Bladder Pain Syndrome.

Biomedicines·2026
Same author

Treatment-Specific Clinical and Urinary Biomarker Signatures Associated With Response to Intravesical Botulinum Toxin A and Platelet-Rich Plasma in Bladder Pain Syndrome.

Lower urinary tract symptoms·2026
Same author

Functional bladder capacity can reflect the bladder condition and treatment outcome in patients with interstitial cystitis/bladder pain syndrome.

World journal of urology·2026
Same author

Predicting Prostatic Obstruction and Bladder Outlet Dysfunction in Men with Lower Urinary Tract Symptoms and Small-to-Moderate Prostate Volume Using Noninvasive Diagnostic Tools.

Biomedicines·2025
Same author

Editorial Comment on Long-Term Clinical Outcome of Transurethral Resection of Hunner Lesions Combined With Bladder Hydrodistention for Patients With Interstitial Cystitis at a Tertiary Center in Japan.

International journal of urology : official journal of the Japanese Urological Association·2025
Same author

Urodynamic Predictive Factors for Successful Treatment Outcomes Following Intravesical Botulinum Toxin a Injection in Patients with Detrusor Overactivity.

Biomedicines·2025

Related Experiment Video

Updated: Jan 27, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.4K

Pathophysiology of refractory overactive bladder.

Li-Chen Chen1,2, Hann-Chorng Kuo3

  • 1Department of Urology, Mackay Memorial Hospital, Taipei, Taiwan.

Lower Urinary Tract Symptoms
|March 23, 2019
PubMed
Summary

Overactive bladder (OAB) often requires advanced treatments when initial therapies fail. This review explores the complex underlying causes of refractory OAB, guiding further medical interventions.

Keywords:
overactive bladderpathophysiologyrefractory overactive bladder

More Related Videos

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

18.3K
Mouse Bladder Wall Injection
03:48

Mouse Bladder Wall Injection

Published on: July 12, 2011

24.8K

Related Experiment Videos

Last Updated: Jan 27, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.4K
Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

18.3K
Mouse Bladder Wall Injection
03:48

Mouse Bladder Wall Injection

Published on: July 12, 2011

24.8K

Area of Science:

  • Urology
  • Nephrology
  • Gerontology

Background:

  • Overactive bladder (OAB) is a prevalent condition affecting urinary urgency, often with frequency and nocturia.
  • First-line treatments, including behavioral modifications and medications, yield satisfactory outcomes in less than half of OAB patients.
  • Refractory OAB necessitates exploring second-line therapies like botulinum toxin injections, neuromodulation, or surgery when initial treatments are insufficient.

Purpose of the Study:

  • To elucidate the diverse and complex pathophysiologies contributing to refractory overactive bladder.
  • To provide a comprehensive overview of potential underlying causes not addressed by standard OAB treatments.
  • To inform clinical decision-making for patients with persistent OAB symptoms.

Main Methods:

  • Literature review of studies on overactive bladder pathophysiology.
  • Analysis of potential causes for treatment-resistant OAB.
  • Synthesis of current understanding regarding refractory OAB mechanisms.

Main Results:

  • Refractory OAB can stem from various underlying issues, including occult neurogenic bladder and bladder outlet obstruction.
  • Urethral dysfunction, aging-related urothelial changes, chronic bladder ischemia, and inflammation are implicated in persistent OAB.
  • Central sensitization and autonomic dysfunction represent additional pathophysiological factors in refractory OAB cases.

Conclusions:

  • Understanding the multifaceted pathophysiologies of refractory OAB is crucial for effective patient management.
  • Identifying specific underlying causes can guide the selection of advanced treatment strategies.
  • Further research into these complex mechanisms may lead to novel therapeutic approaches for intractable OAB.